Mats Bläckberg

Medicine and Dentistry

1. Patient 100%
2. Cystectomy 56%
3. Bladder Cancer 30%
4. Fluorodeoxyglucose F 18 25%
5. Surgery 25%
6. Arterial Embolization 24%
7. Positron Emission Tomography-Computed Tomography 24%
8. Therapeutic Procedure 23%
9. Cystoscopy 19%
10. Induction Chemotherapy 17%
11. Lymph Node 16%
12. Ileal Conduit 16%
13. Parastomal Hernia 16%
14. Urethra 16%
15. Outpatient 16%
16. Transurethral Resection 14%
17. Biopsy 14%
18. Complication 13%
19. Health Care Cost 13%
20. Specimen 13%
21. Follow up 13%
22. Carcinoma in Situ 12%
23. Bladder 12%
24. Chemotherapy 11%
25. Experience 11%
26. Lymph Node Metastasis 11%
27. Quality of Life 11%
28. Disease 10%
29. Urinary Diversion 9%
30. Microhematuria 9%
31. Retroperitoneal Lymph Node Dissection 8%
32. Age 8%
33. Prospective Study 8%
34. Retrospective Study 8%
35. Postoperative Complication 8%
36. Cost-Effectiveness Analysis 8%
37. Metabolism 8%
38. Health 8%
39. RNA Sequence 8%
40. Cancer Therapy 8%
41. Hospital 8%
42. Development 7%
43. Examination 6%
44. Man 6%
45. Hazard Ratio 6%
46. Lesion 6%
47. Arm 6%
48. Patient Referral 5%